Current Report Filing (8-k)
04 3월 2020 - 10:54PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(d)
OF
THE SECURITIES EXCHANGE ACT OF 1934
Date
of Report (Date of earliest event reported): March 3, 2020
Health
Insurance Innovations, Inc.
(Exact
name of registrant as specified in its charter)
Delaware
|
|
001-35811
|
|
46-1282634
|
(State
or other jurisdiction
of
incorporation)
|
|
(Commission
File
Number)
|
|
(IRS
Employer
Identification
No.)
|
15438
N. Florida Avenue, Suite 201
Tampa,
Florida
|
|
33613
|
(Address
of principal executive offices)
|
|
(Zip
Code)
|
Registrant’s
telephone number, including area code: (813) 397-1187
Not
Applicable
(Former
name or former address, if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
[ ]
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
[ ]
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each class
|
|
Trading
Symbol(s)
|
|
Name
of each exchange on which registered
|
Class
A Common Stock, $0.001 par value
|
|
HIIQ
|
|
Nasdaq
Global Market
|
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR
§230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company [ ]
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]
Item
2.02.
|
Results
of Operations and Financial Condition.
|
On
March 3, 2020, Health Insurance Innovations, Inc. (the “Company”) issued a press release announcing its financial
results for the year ended December 31, 2019. A copy of the press release is furnished as Exhibit 99.1 to this Current Report
on Form 8-K.
The
information furnished in this Item 2.02, including Exhibit 99.1, is not deemed to be “filed” for purposes of Section
18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liability
of that section. This information will not be deemed to be incorporated by reference into any filing under the Securities Act
of 1933, as amended, or the Exchange Act, except to the extent that the registrant specifically incorporates it by reference.
Item
9.01.
|
Financial
Statements and Exhibits.
|
(d)
Exhibits.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
|
HEALTH
INSURANCE INNOVATIONS, INC.
|
|
|
|
|
By:
|
/s/
Erik M. Helding
|
|
Name:
|
Erik
M. Helding
|
|
Title:
|
Chief
Financial Officer
|
Date:
March 4, 2020
Health Insurance Innovat... (NASDAQ:HIIQ)
과거 데이터 주식 차트
부터 8월(8) 2024 으로 9월(9) 2024
Health Insurance Innovat... (NASDAQ:HIIQ)
과거 데이터 주식 차트
부터 9월(9) 2023 으로 9월(9) 2024
Health Insurance Innovations Inc (나스닥)의 실시간 뉴스: 최근 기사 0
More Health Insurance Innovations, Inc. News Articles